Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Wedbush Downgrades AnaptysBio to Neutral


Benzinga | Mar 9, 2021 09:18AM EST

Wedbush Downgrades AnaptysBio to Neutral

Wedbush analyst David Nierengarten downgrades AnaptysBio (NASDAQ:ANAB) from Outperform to Neutral.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC